Biomics Biopharma (ASX:BBM) EPS (Basic) : A$ (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma EPS (Basic)?

Biomics Biopharma's basic earnings per share (Basic EPS) for the six months ended in . 20 was A$0.00. Biomics Biopharma does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Biomics Biopharma's EPS (Diluted) for the six months ended in . 20 was A$0.00. Biomics Biopharma does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Biomics Biopharma's EPS without NRI for the six months ended in . 20 was A$0.00. Biomics Biopharma does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Biomics Biopharma EPS (Basic) Historical Data

The historical data trend for Biomics Biopharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma EPS (Basic) Chart

Biomics Biopharma Annual Data

Trend

EPS (Basic)

Biomics Biopharma Semi-Annual Data

EPS (Basic)

Biomics Biopharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biomics Biopharma's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Biomics Biopharma's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Biomics Biopharma (ASX:BBM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biomics Biopharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » EPS (Basic)

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines